SCYNEXIS INC
Public company- Headquarters
- JERSEY CITY, New Jersey
- Ticker
- SCYX
- CIK
- 0001178253
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| member of the BoardSteven K. Burke, M.D. | Sep 22, 2026 | Appointed |
| CFOIvor Macleod, CPA, MBA | Sep 10, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
member of the Board appointed: Steven K. Burke, M.D.
Steven K. Burke, M.D. was named member of the Board of SCYNEXIS INC, effective September 18, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 22, 2026Role: member of the Board
- Executive departure
CFO departs: Ivor Macleod, CPA, MBA
Ivor Macleod, CPA, MBA, Chief Financial Officer of SCYNEXIS INC, departs the role, effective September 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Chief Financial Officer
- Executive appointment
CFO appointed: Sanjay Subramanian, MBA
Sanjay Subramanian, MBA was named Chief Financial Officer of SCYNEXIS INC, effective September 9, 2026. Sanjay Subramanian, MBA succeeds Ivor Macleod, CPA, MBA. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Chief Financial Officer
Last verified Nov 8, 2026